Christopher Verni
General Counsel at VIGIL NEUROSCIENCE, INC.
Net worth: 12 720 $ as of 2024-05-30
Christopher Verni active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIGIL NEUROSCIENCE, INC. | General Counsel | 2022-04-19 | - |
Career history of Christopher Verni
Former positions of Christopher Verni
| Companies | Position | Start | End |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2013-11-30 | 2022-03-31 |
| ARIAD PHARMACEUTICALS, INC. | General Counsel | 2011-09-30 | 2013-10-31 |
| Sanofi SA | General Counsel | 2007-04-30 | 2011-09-30 |
| PFIZER, INC. | General Counsel | 2004-04-30 | 2007-04-30 |
Training of Christopher Verni
| University of New Hampshire School of Law | Graduate Degree |
| Rochester Christian University | Undergraduate Degree |
Statistics
International
| United States | 7 |
| France | 2 |
Operational
| General Counsel | 4 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi SA | Health Technology |
- Stock Market
- Insiders
- Christopher Verni
- Experience
